Drugs / CTL0902
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05009368 | Jul → Oct 2021 | — | Celltrion | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CTL0902 | “CTL0902, single dose, daily, repeated oral administration for 7 days” NCT05009368 ↗ |
| Route | Oral | “repeated oral administration for 7 days” NCT05009368 ↗ |